First home testing kit for cervical cancer approved by the FDA

Washington – American regulators approved the first cervical cancer test kit which allows women to recover their own sample at home before shipping it in a laboratory, according to a medical devices.

Teal Health said on Friday that Food and Drug Administration approved its Turacine wand for domestic use, offering a new way of collecting vaginal samples that can detect the VPH virus that causes cervical cancer. Currently, HPV tests and PAP smear are carried out in a health clinic or a doctor’s office.

An influential federal panel recommended last year the use of auto-collects of HPV samples to increase screening. The FDA has also recently expanded the use of two older HPV tests for collecting self-collecting, but these must be carried out in a medical office or a mobile clinic.

HUMV, or human papillomavirus, is very common and spreads through sex. Most HPV infections have cleared up by themselves, but persistent infection can cause cervical cancer. Most cervical cancers occur in women insufficiently detected, diagnosed or treated.

To collect a sample, a swab or a brush is inserted into the vagina and turned, then the swab is placed in a tube or a container and treated in a laboratory.

The Teal Health Kit requires a prescription, which customers can obtain via one of the company’s online health suppliers. The company based in San Francisco said that it would initially start selling the kits in California next month before expanding to other states. The company also said that it worked with insurers on the test of the test.